ISSN 1662-4009 (online)

Previous issue | Volume 17 | ESPEYB17 | Next issue

Yearbook of Paediatric Endocrinology 2020

9. Oncology and Chronic Disease

Cancer Treatment, Growth and Growth Hormone

ey0017.9-17 | Cancer Treatment, Growth and Growth Hormone | ESPEYB17

9.17. Final height in growth hormone-deficient childhood cancer survivors after growth hormone therapy

G Rodari , A Cattoni , A Albanese

To read the full abstract: J Endocrinol Invest. 2020 Feb;43(2):209–217. giulia.rodari@unimi.itGrowth hormone deficiency (GHD) is the most common endocrine late effect in children with tumours involving the hypothalamus-pituitary (HP) area or exposed to cranial, craniospinal or total body radiotherapy (RT). The location of brain tumours in continuity with the sellar/suprasellar area and HP radiatio...